source
- Patient with EGFR-mutated NSCLC develops brain metastases after first-line EGFR inhibitor and chemotherapyDr. Sands presented a case of a patient with metastatic non-small cell lung cancer that carries an EGFR mutation. The patient was treated with a first-line regimen that combined an EGFR tyrosine k…